Edition:
United Kingdom

People: Sul America SA (SULA11.SA)

SULA11.SA on Sao Paulo Stock Exchange

42.87BRL
19 Jul 2019
Change (% chg)

R$ -0.50 (-1.15%)
Prev Close
R$ 43.37
Open
R$ 43.50
Day's High
R$ 43.56
Day's Low
R$ 42.52
Volume
1,098,400
Avg. Vol
1,190,240
52-wk High
R$ 43.56
52-wk Low
R$ 21.11

Lorne Levy, David 

Mr. David Lorne Levy serves as the Independent Director of Sul America S.A. since January 10, 2014. He currently works as an independent consultant for PwC Global Health Industries, where he was Chief Executive Officer (CEO) between 2005 and 2013 and was hired with the purpose of re-launching the healthcare information technology program. Before joining PwC, he was the CEO of Franklin Health Inc., a company he founded. He has worked, since 1983, in the development of enterprises in the medical and healthcare fields. He was the CEO of Corning Franklin Health and of Franklin Health - Personal Path Systems. He received a Doctor of Medicine and Masters degree from McGill University. He is also a member of the American College of Preventative Medicine, has worked as a professor in several medical institutions in the United States and is a Director of the United Hospital Fund of New York City and of The Atlantic Council.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --